Global Bioresorbable Drug-Eluting Stents Market Growth 2025-2031

The global Bioresorbable Drug-Eluting Stents market size is predicted to grow from US$ 521 million in 2025 to US$ 1068 million in 2031; it is expected to grow at a CAGR of 12.7% from 2025 to 2031.

The bioabsorbable drug-eluting stent consists of a stent and a delivery system. The stent consists of three parts: a stent matrix, a developing marker, and a drug carrier coating. It is used to treat intravascular stenosis in patients with primary coronary atherosclerosis, improve coronary blood flow and prevent restenosis.

Biodegradable stents are the development direction of coronary stents, which can solve the pain point of permanent foreign bodies in drug-eluting metal stents. Cardiac stents are mainly used in the treatment of coronary heart disease. Coronary interventional therapy (PCI) has experienced three generations of technical development: relay balloon dilatation, bare metal stent (BMS) and drug-eluting stent (DES). At present, most of the stents used in the world are the third-generation stents - drug-eluting stents. Since their materials are metal, metal foreign bodies will permanently remain in the human body after implantation. The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation, and can restore the function and elasticity of blood vessels without permanent retention, so it is considered the fourth revolution in the treatment of coronary heart disease.

LP Information, Inc. (LPI) ' newest research report, the “Bioresorbable Drug-Eluting Stents Industry Forecast” looks at past sales and reviews total world Bioresorbable Drug-Eluting Stents sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Drug-Eluting Stents sales for 2025 through 2031. With Bioresorbable Drug-Eluting Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Drug-Eluting Stents industry.

This Insight Report provides a comprehensive analysis of the global Bioresorbable Drug-Eluting Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Drug-Eluting Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Drug-Eluting Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Drug-Eluting Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Drug-Eluting Stents.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Drug-Eluting Stents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Metal Base Stent

Polymer Stent

Segmentation by Application:

Hospital

Specialty Clinic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Abbott

Boston Scientific

Biotronik

Shanghai Bioheart Biological Technology

LifeTech Scientific

Lepu Medical Technology

Microport

Shandong Huaan Biotechnology

Shenzhen Salubris Biomedical Engineering

Beijing Advanced Medical Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bioresorbable Drug-Eluting Stents market?

What factors are driving Bioresorbable Drug-Eluting Stents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bioresorbable Drug-Eluting Stents market opportunities vary by end market size?

How does Bioresorbable Drug-Eluting Stents break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.